Differentiated Service Delivery for Antiretroviral Therapy

Sponsor
Thai Red Cross AIDS Research Centre (Other)
Overall Status
Recruiting
CT.gov ID
NCT04383769
Collaborator
(none)
5,000
1
72
69.4

Study Details

Study Description

Brief Summary

This study is a prospective observational cohort. The target study population is PLHIV who receive ART at hospitals and community-based organizations (CBOs) in Chiang Mai, Ubon Ratchathani, Chonburi, and Songkhla. Participants will receive ART service in the same standard as in the hospital setting. Secondary data will be collected from the medical records already existed in the hospital and CBO systems.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaires survey

Detailed Description

DSD-ART service at the Hospital

  • Medical examination: All clients who receive ART service at the hospital and agree to participate in the research project will be interviewed to collect personal information and receive physical and laboratory examination in order to assess eligibility in research participation. If ineligible, the clients will be referred to the standard of care.

  • Preparation and DSD-ART service offer: PLHIV who are eligible to participate in the research will receive counselling to assess the supports the clients need and will be offered various models of DSD-ART service. The clients may choose the model that is most suitable to their lifestyle.

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Differentiated Service Delivery for Antiretroviral Therapy
Actual Study Start Date :
Dec 15, 2019
Anticipated Primary Completion Date :
Dec 15, 2022
Anticipated Study Completion Date :
Dec 15, 2025

Arms and Interventions

Arm Intervention/Treatment
5,000 participants:

2,500 are PLHIV receiving standard care in the hospital and 2,500 are PLHIV receiving care in DSD-ART model Inclusion criteria: Thai citizenship Age ≥ 18 HIV positive Received ART for at least 6 months at a participating hospital (Except for After hour ART clinic model that will allow participants who receive ART less than 6 months into service) One of the following: Accept DSD-ART, OR Already receiving DSD-ART, OR Decline DSD-ART and will continue standard ART service at the hospital.

Other: questionnaires survey
data will be collected from the medical records already existed in the hospital and community-based organization (CBO) systems and entered into case report form (CRF). The expected number of participants is 5000. For each participant, the data will be collected prospectively for 24 months and retrospectively up to 5 years from the screening date. This study has no intervention and will not alter ART services whether be standard or DSD-ART at hospitals.

Outcome Measures

Primary Outcome Measures

  1. differentiated service delivery for antiretroviral therapy (DSD-ART) [5 years]

    1. To assess retention among people living with HIV (PLHIV) in various models of differentiated service delivery for antiretroviral therapy (DSD-ART) Hypothesis: The proportions of PLHIV with high ART retention in each DSD-ART model are similar and not inferior to standard-of-care historical data

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Thai citizenship

  2. Age ≥ 18

  3. HIV positive

  4. Received ART for at least 6 months at a participating hospital (Except for After hour ART clinic model that will allow participants who receive ART less than 6 months into service)

Exclusion Criteria:

N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 3. Swing Dic, Chon Buri Thailand

Sponsors and Collaborators

  • Thai Red Cross AIDS Research Centre

Investigators

  • Principal Investigator: Nittaya Phanuphak, MD,Ph.D, Institute of HIV Research and Innovation (IHRI)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thai Red Cross AIDS Research Centre
ClinicalTrials.gov Identifier:
NCT04383769
Other Study ID Numbers:
  • DSD-ART
First Posted:
May 12, 2020
Last Update Posted:
Jul 9, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 9, 2021